vs
PAMT CORP（PAMT）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是PAMT CORP的1.4倍（$197.9M vs $141.3M），REPLIGEN CORP净利率更高（6.7% vs -20.7%，领先27.4%），REPLIGEN CORP同比增速更快（13.6% vs -15.1%），REPLIGEN CORP自由现金流更多（$17.6M vs $-25.0M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -12.0%）
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PAMT vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.4倍
$141.3M
营收增速更快
RGEN
高出28.8%
-15.1%
净利率更高
RGEN
高出27.4%
-20.7%
自由现金流更多
RGEN
多$42.5M
$-25.0M
两年增速更快
RGEN
近两年复合增速
-12.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $141.3M | $197.9M |
| 净利润 | $-29.3M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | -27.0% | 9.0% |
| 净利率 | -20.7% | 6.7% |
| 营收同比 | -15.1% | 13.6% |
| 净利润同比 | 7.4% | 143.9% |
| 每股收益（稀释后） | $-1.38 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PAMTRGEN
| Q4 25 | $141.3M | $197.9M | ||
| Q3 25 | $150.3M | $188.8M | ||
| Q2 25 | $151.1M | $182.4M | ||
| Q1 25 | $155.3M | $169.2M | ||
| Q4 24 | $166.5M | $174.1M | ||
| Q3 24 | $182.6M | $154.9M | ||
| Q2 24 | $182.9M | $154.1M | ||
| Q1 24 | $182.6M | $151.3M |
净利润PAMTRGEN
| Q4 25 | $-29.3M | $13.3M | ||
| Q3 25 | $-5.6M | $14.9M | ||
| Q2 25 | $-9.6M | $14.9M | ||
| Q1 25 | $-8.1M | $5.8M | ||
| Q4 24 | $-31.6M | $-30.3M | ||
| Q3 24 | $2.4M | $-654.0K | ||
| Q2 24 | $-2.9M | $3.3M | ||
| Q1 24 | $281.0K | $2.1M |
毛利率PAMTRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率PAMTRGEN
| Q4 25 | -27.0% | 9.0% | ||
| Q3 25 | -3.8% | 8.9% | ||
| Q2 25 | -7.3% | 7.6% | ||
| Q1 25 | -5.9% | 3.9% | ||
| Q4 24 | -22.6% | -17.7% | ||
| Q3 24 | 1.3% | -5.1% | ||
| Q2 24 | -0.4% | 1.0% | ||
| Q1 24 | -0.4% | 1.3% |
净利率PAMTRGEN
| Q4 25 | -20.7% | 6.7% | ||
| Q3 25 | -3.7% | 7.9% | ||
| Q2 25 | -6.4% | 8.2% | ||
| Q1 25 | -5.2% | 3.4% | ||
| Q4 24 | -19.0% | -17.4% | ||
| Q3 24 | 1.3% | -0.4% | ||
| Q2 24 | -1.6% | 2.2% | ||
| Q1 24 | 0.2% | 1.4% |
每股收益（稀释后）PAMTRGEN
| Q4 25 | $-1.38 | $0.24 | ||
| Q3 25 | $-0.27 | $0.26 | ||
| Q2 25 | $-0.46 | $0.26 | ||
| Q1 25 | $-0.37 | $0.10 | ||
| Q4 24 | $-1.44 | $-0.55 | ||
| Q3 24 | $0.11 | $-0.01 | ||
| Q2 24 | $-0.13 | $0.06 | ||
| Q1 24 | $0.01 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $83.7M | $767.6M |
| 总债务越低越好 | $333.9M | $542.2M |
| 股东权益账面价值 | $210.5M | $2.1B |
| 总资产 | $697.9M | $2.9B |
| 负债/权益比越低杠杆越低 | 1.59× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PAMTRGEN
| Q4 25 | $83.7M | $767.6M | ||
| Q3 25 | $115.6M | $748.7M | ||
| Q2 25 | $117.3M | $708.9M | ||
| Q1 25 | $102.7M | $697.2M | ||
| Q4 24 | $110.7M | $757.4M | ||
| Q3 24 | $92.3M | $784.0M | ||
| Q2 24 | $114.0M | $809.1M | ||
| Q1 24 | $125.8M | $780.6M |
总债务PAMTRGEN
| Q4 25 | $333.9M | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $325.6M | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PAMTRGEN
| Q4 25 | $210.5M | $2.1B | ||
| Q3 25 | $239.5M | $2.1B | ||
| Q2 25 | $244.9M | $2.1B | ||
| Q1 25 | $269.6M | $2.0B | ||
| Q4 24 | $277.5M | $2.0B | ||
| Q3 24 | $308.9M | $2.0B | ||
| Q2 24 | $306.7M | $2.0B | ||
| Q1 24 | $314.6M | $2.0B |
总资产PAMTRGEN
| Q4 25 | $697.9M | $2.9B | ||
| Q3 25 | $715.2M | $2.9B | ||
| Q2 25 | $707.9M | $2.9B | ||
| Q1 25 | $712.6M | $2.9B | ||
| Q4 24 | $741.7M | $2.8B | ||
| Q3 24 | $756.7M | $2.8B | ||
| Q2 24 | $733.5M | $2.9B | ||
| Q1 24 | $746.4M | $2.8B |
负债/权益比PAMTRGEN
| Q4 25 | 1.59× | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.17× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.8M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-25.0M | $17.6M |
| 自由现金流率自由现金流/营收 | -17.7% | 8.9% |
| 资本支出强度资本支出/营收 | 13.6% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-23.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流PAMTRGEN
| Q4 25 | $-5.8M | $25.7M | ||
| Q3 25 | $5.9M | $48.1M | ||
| Q2 25 | $12.2M | $28.6M | ||
| Q1 25 | $5.0M | $15.0M | ||
| Q4 24 | $15.2M | $39.2M | ||
| Q3 24 | $15.5M | $49.3M | ||
| Q2 24 | $18.7M | $42.2M | ||
| Q1 24 | $9.6M | $44.7M |
自由现金流PAMTRGEN
| Q4 25 | $-25.0M | $17.6M | ||
| Q3 25 | $2.5M | $43.4M | ||
| Q2 25 | $5.9M | $21.5M | ||
| Q1 25 | $-6.8M | $11.4M | ||
| Q4 24 | $-39.9M | $33.6M | ||
| Q3 24 | $-33.6M | $42.3M | ||
| Q2 24 | $4.1M | $37.4M | ||
| Q1 24 | $-12.2M | $36.4M |
自由现金流率PAMTRGEN
| Q4 25 | -17.7% | 8.9% | ||
| Q3 25 | 1.7% | 23.0% | ||
| Q2 25 | 3.9% | 11.8% | ||
| Q1 25 | -4.4% | 6.8% | ||
| Q4 24 | -24.0% | 19.3% | ||
| Q3 24 | -18.4% | 27.3% | ||
| Q2 24 | 2.2% | 24.3% | ||
| Q1 24 | -6.7% | 24.0% |
资本支出强度PAMTRGEN
| Q4 25 | 13.6% | 4.1% | ||
| Q3 25 | 2.3% | 2.5% | ||
| Q2 25 | 4.2% | 3.9% | ||
| Q1 25 | 7.6% | 2.1% | ||
| Q4 24 | 33.1% | 3.2% | ||
| Q3 24 | 26.9% | 4.5% | ||
| Q2 24 | 8.0% | 3.1% | ||
| Q1 24 | 12.0% | 5.5% |
现金转化率PAMTRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.44× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | 34.11× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PAMT
| Freight Transportation Service | $123.1M | 87% |
| Fuel Surcharge | $18.2M | 13% |
RGEN
暂无分部数据
